Misuse of Drugs (Pseudoephedrine) Amendment Bill

Front page of Misuse of Drugs (Pseudoephedrine) Amendment Bill

11 Apr 2024

Health Committee.

In accordance with the Government’s commitment to allow the sale of cold and flu medication containing pseudoephedrine, the purpose of this Bill is to change the classification of pseudoephedrine as a controlled drug. This Bill reclassifies pseudoephedrine from a Class B2 to a Class C3 controlled drug under the Misuse of Drugs Act 1975, so that cold and flu products containing pseudoephedrine can be sold in pharmacies without a prescription. The different classes of controlled drugs are described in regulation 25(2) of the Misuse of Drugs Regulations 1977.

Read more

Other stories

Academic Literature
New Zealand Pae Ora Healthcare Reforms 2022: Viable by Design? A Qualitative Study Using the Viable System Model

New Zealand Pae Ora Healthcare Reforms 2022: Viable by Design? A Qualitative Study Using the Viable System Model

The New Zealand (NZ) Pae Ora (Healthy Futures) health reforms came into effect in July 2022 with the establishment of Health New Zealand (HNZ) (Te Whatu Ora) and the Māori Health Authority (MHA) (Te Aka Whai Ora) – the organisations charged for healthcare provision...

Key issues

HEALTH SERVICES AND SYSTEMS

Covering developments in the provision, funding and organisation of health care services.

EQUITY

Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.

DRUGS, DEVICE AND DIAGNOSTICS

Covering prescription medicines and medical devices.

PUBLIC HEALTH

Focusing on efforts to promote health and prevent disease through social and economic interventions.

DIGITAL HEALTH

Exploring the potential digital transformation to provide a more connected and accessible health system.

TE TIRITI

Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.